Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBeetstra, S.-
dc.contributor.authorSalisbury, C.-
dc.contributor.authorTurner, J.-
dc.contributor.authorAltree, M.-
dc.contributor.authorMcKinnon, R.-
dc.contributor.authorSuthers, G.-
dc.contributor.authorFenech, M.-
dc.identifier.citationCarcinogenesis, 2006; 27(3):517-524-
dc.description.abstractMutations in BRCA1 and BRCA2 genes may cause defective DNA repair and increase risk for breast cancer. Folate deficiency is associated with increased breast cancer risk and induces chromosome abnormalities. We hypothesised that BRCA1 and BRCA2 germ-line mutation carriers are more sensitive to the genome damaging effect of folate deficiency compared to healthy non-carrier controls and that this sensitivity is further increased in those carriers who develop breast cancer. We tested these hypotheses in lymphocytes cultured in medium containing 12 nM or 120 nM folic acid (FA) for 9 days and measured proliferative capacity and chromosomal instability using the cytokinesis-block micronucleus (CBMN) assay. BRCA1 and BRCA2 mutation carriers with or without breast cancer were not abnormally sensitive to FA deficiency-induced chromosome instability however BRCA2 mutation carriers had significantly reduced cell proliferation. FA deficiency reduced cell proliferation and increased micronucleus formation significantly accounting for 45-59% and 70-75% of the variance in these parameters compared to 0.3-8.5% and 0.2-0.3% contributed by BRCA1 or BRCA2 mutation carrier status respectively. The results of this study suggest that moderate folate deficiency has a stronger effect on chromosomal instability than BRCA1 or BRCA2 mutations found in breast cancer families.-
dc.description.statementofresponsibilitySasja Beetstra, Carolyn Salisbury, Julie Turner, Meryl Altree, Ross McKinnon, Graeme Suthers and Michael Fenech-
dc.publisherOxford Univ Press-
dc.rights© The Author 2005.-
dc.subjectBreast cancer-
dc.subjectfolic acid-
dc.subjectmicronucleus assay.-
dc.titleLymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency-
dc.typeJournal article-
dc.identifier.orcidFenech, M. [0000-0002-8466-0991]-
Appears in Collections:Aurora harvest 6
Pharmacology publications

Files in This Item:
File Description SizeFormat 
hdl_22774.pdf118.9 kBPublisher's PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.